Literature DB >> 18471882

Differential regulation of cytokine production by PI3Kdelta in human monocytes upon acute and chronic inflammatory conditions.

Nicolas Molnarfi1, Karim J Brandt, Lyssia Gruaz, Jean-Michel Dayer, Danielle Burger.   

Abstract

Deregulated production of cytokines, including IL-1beta, IL-6 and TNF plays an important role in chronic inflammation. Relevant to this condition, direct cellular contact with stimulated T cells is a potent inducer of cytokine production in human monocytes/macrophages. We previously demonstrated that PI3Ks regulate differential production of IL-1beta and its specific inhibitor secreted IL-1 receptor antagonist (sIL-1Ra) by human monocytes. Here we show that in contrast with PI3Kalpha, beta and gamma, PI3Kdelta accounts for most of the PI3K-dependent signaling ruling the production of IL-1beta, IL-6, TNF and sIL-1Ra in monocytes activated by cellular contact with stimulated T cells (mimicked by CHAPS-solubilized membranes of stimulated T cells, CE sHUT) and lipopolysaccharides (LPS); the latter stimuli being relevant to chronic/sterile and acute/infectious inflammation, respectively. Interestingly, PI3Kdelta activity dampened the production of pro-inflammatory cytokines in LPS-activated monocytes, but induced it in CE sHUT-activated cells. In both CE sHUT- and LPS-activated monocytes PI3Kdelta regulated cytokine transcript expression through the phosphorylation/inactivation of glycogen synthase kinase-3beta (GSK3beta). The blockade of GSK3beta displayed inverse effects to those of PI3Kdelta blockade. Thus, by displaying opposite functions in conditions mimicking chronic/sterile and acute/infectious inflammation, i.e., by repressing pro-inflammatory cytokine expression in LPS-activated monocytes but inducing such mediators in T cell contact-activated monocytes, PI3Kdelta represents a potential therapeutic target specific to chronic/sterile inflammatory conditions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18471882     DOI: 10.1016/j.molimm.2008.04.001

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  8 in total

1.  Glatiramer acetate triggers PI3Kδ/Akt and MEK/ERK pathways to induce IL-1 receptor antagonist in human monocytes.

Authors:  Rakel Carpintero; Karim J Brandt; Lyssia Gruaz; Nicolas Molnarfi; Patrice H Lalive; Danielle Burger
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-27       Impact factor: 11.205

2.  Blockade of T cell contact-activation of human monocytes by high-density lipoproteins reveals a new pattern of cytokine and inflammatory genes.

Authors:  Lyssia Gruaz; Céline Delucinge-Vivier; Patrick Descombes; Jean-Michel Dayer; Danielle Burger
Journal:  PLoS One       Date:  2010-02-25       Impact factor: 3.240

3.  A phase 2 study of idelalisib plus rituximab in treatment-naïve older patients with chronic lymphocytic leukemia.

Authors:  Susan M O'Brien; Nicole Lamanna; Thomas J Kipps; Ian Flinn; Andrew D Zelenetz; Jan A Burger; Michael Keating; Siddhartha Mitra; Leanne Holes; Albert S Yu; David M Johnson; Langdon L Miller; Yeonhee Kim; Roger D Dansey; Ronald L Dubowy; Steven E Coutre
Journal:  Blood       Date:  2015-10-15       Impact factor: 22.113

Review 4.  Overcoming reduced glucocorticoid sensitivity in airway disease: molecular mechanisms and therapeutic approaches.

Authors:  John A Marwick; Ian M Adcock; Kian Fan Chung
Journal:  Drugs       Date:  2010-05-28       Impact factor: 9.546

5.  IFNβ and glatiramer acetate trigger different signaling pathways to regulate the IL-1 system in multiple sclerosis.

Authors:  Rakel Carpintero; Danielle Burger
Journal:  Commun Integr Biol       Date:  2011-01

Review 6.  Metabolomics--a novel window into inflammatory disease.

Authors:  Martin Fitzpatrick; Stephen P Young
Journal:  Swiss Med Wkly       Date:  2013-01-21       Impact factor: 2.193

7.  PI3kα and STAT1 Interplay Regulates Human Mesenchymal Stem Cell Immune Polarization.

Authors:  Marwan Mounayar; Eirini Kefaloyianni; Brian Smith; Zhabiz Solhjou; Omar H Maarouf; Jamil Azzi; Lola Chabtini; Paolo Fiorina; Morey Kraus; Robert Briddell; William Fodor; Andreas Herrlich; Reza Abdi
Journal:  Stem Cells       Date:  2015-06       Impact factor: 6.277

Review 8.  Cytokines in chronic rheumatic diseases: is everything lack of homeostatic balance?

Authors:  Carlo Chizzolini; Jean-Michel Dayer; Pierre Miossec
Journal:  Arthritis Res Ther       Date:  2009-10-14       Impact factor: 5.156

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.